Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of cancers by expression profiling.

Edison T Liu1

  • 1Genome Institute of Singapore, Singapore Science Park II, Singapore. gisliue@nus.edu.sg

Current Opinion in Genetics & Development
|February 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Differential assembly of mouse and human tumor microenvironments.

Nature immunology·2026
Same author

Prevalence of <i>BRCA1</i> Promoter Methylation in Cohorts of Individuals With and Without Cancer Assessed by Circulating Cell-Free DNA.

JCO precision oncology·2026
Same author

Defective BRCA1-mediated DNA end resection drives tandem duplication formation and <i>FANCM</i> synthetic lethality.

bioRxiv : the preprint server for biology·2026
Same author

Molecular Systems Biology at 20: reflecting on the past, envisioning the future.

Molecular systems biology·2025
Same author

Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response.

Cell reports·2025
Same journal

Temporal trajectories underlying adult neuronal diversity.

Current opinion in genetics & development·2026
Same journal

Transcription regulation of cell fate plasticity - from embryonic development to tissue regeneration.

Current opinion in genetics & development·2026
Same journal

Shared molecular and cellular programs during regeneration of glandular epithelia.

Current opinion in genetics & development·2026
Same journal

Lineage tracing in human cortical development.

Current opinion in genetics & development·2026
Same journal

Cis-regulatory strategies in developmental patterning.

Current opinion in genetics & development·2026
Same journal

GABAergic neuron fate specification and lineage allocation: from development to disorder.

Current opinion in genetics & development·2026
See all related articles

Microarray expression profiling advances cancer classification, particularly in lymphomas, leukaemias, and breast cancer. This technology reveals new diagnostic categories and prognostic profiles, aiding in identifying novel biomarkers and therapeutic targets.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Cancer classification traditionally relies on microscopy and molecular methods.
  • Limitations exist in standard methods for identifying distinct cancer sub-categories.
  • Understanding cancer at the molecular level is crucial for improved diagnostics and therapeutics.

Purpose of the Study:

  • To evaluate the impact of expression profiling using microarray technology on cancer classification.
  • To identify new diagnostic categories and prognostic profiles in various cancers.
  • To explore the potential of microarray data for discovering novel diagnostic markers and therapeutic targets.

Main Methods:

  • Utilized microarray technology for large-scale gene expression profiling.
  • Analyzed expression data to refine cancer classification, focusing on lymphomas, leukaemias, and breast cancer.

Related Experiment Videos

  • Correlated expression profiles with diagnostic and prognostic information.
  • Main Results:

    • Microarray profiling has significantly refined cancer classification, especially in lymphomas, leukaemias, and breast cancer.
    • Identified novel diagnostic sub-categories previously undetectable by standard methods.
    • These sub-categories exhibit distinct prognostic profiles, clarifying cellular lineage and biochemical pathways.

    Conclusions:

    • Expression profiling via microarrays offers powerful insights into cancer heterogeneity.
    • This technology facilitates the discovery of new diagnostic markers and therapeutic targets.
    • Microarray-based classification improves prognostic accuracy and understanding of cancer biology.